Mabtech AB is a privay owned biotech company founded in 1986. Emerging from the Department of Immunology at Stockholm University, Mabtech has become a world leader in ELISpot and T-cell measurements. Representing one of the most sensitive and easiest methods to analyze specific T-cell responses, the ELISpot is ideal whenever studying the role of T cells in e.g. infections, cancer, allergy and autoimmune disease. With its straightforward performance and the possibility to screen large number of samples, the ELISpot has become a standard method in the research and clinical evaluations of new vaccines. To supplement the ELISpot products, we have recently launched a series of complete, ready-to-use ELISA kits that allow easy measurements of cytokine levels in various samples including serum and plasma